Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.
about
The Role of Poly(ADP-ribose) Polymerase-1 in Rheumatoid ArthritisHelicobacter pylori activation of PARP-1: usurping a versatile regulator of host cellular healthThe role of necrotic cell death in the pathogenesis of immune mediated nephropathies.Osteoarticular Expression of Musashi-1 in an Experimental Model of ArthritisThe Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1.Association of three SNPs in the PARP-1 gene with Hashimoto's thyroiditis.Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation.B cell-intrinsic and -extrinsic regulation of antibody responses by PARP14, an intracellular (ADP-ribosyl)transferase.PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.Roles of AP-2 transcription factors in the regulation of cartilage and skeletal development.Beyond DNA repair, the immunological role of PARP-1 and its siblings.The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development.Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes.
P2860
Q26785513-831FDF25-A74F-4479-AB45-E3AF13847829Q34664112-6D58F84E-9EF0-4A2B-BC67-4C1248EB6341Q35142272-E3917199-1939-4050-9E45-AA867438F70AQ35612503-2C9C96AC-AFEA-4980-81E7-BEA9B8C8292FQ36132464-D75A5644-1A17-43B1-AD2D-1AA631631BE1Q36671116-299AFF72-6F9C-4296-AFD9-A16157A56F8FQ36786279-10AFA27B-9A53-4811-B002-4904E2C31102Q37164046-F5902DBA-7D4B-4DC7-8F94-9D11280ACEB7Q37377750-DC024FAF-B18A-49E5-B73C-C08AE8904C77Q37668700-3A73527B-331A-42EE-8FEC-F534FAB1F4C9Q38089268-409A1B3E-C745-4CB7-A57F-59DB1A4955D0Q38986446-CD34658D-6EDD-4479-B8B2-1DB5D66C455DQ41535001-1A4A4DDC-4268-40FF-B10F-28582BE18B7BQ48344437-63AC6A5E-9F72-4868-8843-9FD7516A40DF
P2860
Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Therapeutic effect of a poly
@nl
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@ast
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@en
type
label
Therapeutic effect of a poly
@nl
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@ast
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@en
prefLabel
Therapeutic effect of a poly
@nl
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@ast
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@en
P2093
P2860
P1433
P1476
Therapeutic effect of a poly(A ...... inflammation and Th1 response.
@en
P2093
Carmen Conde
Elena Gonzalez-Rey
F Javier Oliver
Francisco O'Valle
Rocío Aguilar-Quesada
Ruben Martínez-Romero
P2860
P356
10.1371/JOURNAL.PONE.0001071
P407
P577
2007-10-31T00:00:00Z